
    
      This is an open-label, non-randomized phase II clinical trial.

      Three different concentrations of three different cat epithelial allergenic extracts,
      together with a positive and negative control, using 10 mg/ml histamine dihydrochloride and a
      glycerated phenol saline solution, respectively, will be tested in every subject on the volar
      surface of the forearm.
    
  